文献速递前列腺增生与排尿功能障碍

单孔经膀胱前列腺剜除术(STEP)治疗大体积(80-150cc)与超大体积(>150cc)前列腺增生的比较分析

Single-port transvesical enucleation of the prostate (STEP) for benign prostatic hyperplasia: a comparative analysis of patients with large (80-150cc) and very large (>150cc) prostate volumes.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2026-02-21

该回顾性研究纳入179例接受达芬奇单孔系统STEP手术的前列腺增生患者,按前列腺体积分为大体积组(80-150cc,93例)和超大体积组(>150cc,86例)。结果显示超大体积组剜除效率更高(1.23 vs. 0.97 g/min,p=0.025),尽管剜除时间和控制台时间更长、估计失血量略高,但两组住院时间、导管留置时间、同日出院率及3个月功能改善和并发症均相当,且无中转或增加端口。

要点

  • STEP对≥80cc前列腺安全有效,超大体积组剜除效率更高。
  • 超大体积组剜除时间、控制台时间及估计失血量略高,但恢复指标相当。
  • 两组3个月IPSS、QoL、Qmax改善无差异,尿控保留良好。

核心结论

  • STEP对≥80cc前列腺有效且可扩展,超大体积腺体剜除效率提高且不损害安全性、恢复或尿控保留。

研究设计与样本

  • 回顾性比较分析,纳入2019-2024年接受达芬奇单孔系统STEP手术的179例患者(大体积组93例,超大体积组86例)。

主要发现

  • 超大体积组中位前列腺体积显著更大(194 vs. 117 cc,p<0.001),PSA更高(9.7 vs. 6.75 ng/mL,p=0.002)。
  • 超大体积组剜除时间更长(84 vs. 69 min,p=0.002),控制台时间更长(115 vs. 98 min,p=0.010),剜除效率更高(1.23 vs. 0.97 g/min,p=0.025),估计失血量略高(100 vs. 80 mL,p=0.026)。
  • 两组住院时间、导管留置时间及同日出院率相当;3个月IPSS(3 vs. 3,p=0.913)、QoL(0 vs. 1,p=0.965)和Qmax(17.5 vs. 16 mL/s,p=0.594)改善无差异。
  • 并发症罕见,无再入院,仅2例重大术后事件;所有患者尿控保留,6例(大体积组2例,超大体积组4例)出现暂时性尿失禁,3个月内完全恢复。

临床怎么用

  • STEP可用于≥80cc前列腺增生,尤其超大体积腺体剜除效率更优。
  • 术后恢复指标和功能改善与大体积腺体相当,尿控保留良好。

局限性

  • 回顾性研究设计,样本量有限,随访仅3个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Single-Port Transvesical Enucleation of the Prostate (STEP) is a minimally invasive robotic technique for managing benign prostatic hyperplasia (BPH), particularly in prostates ≧ 80 cc. However, its outcomes in very large prostates (>150 cc) remain under-characterized. We compared perioperative and functional outcomes of STEP between large (LP: 80-150 cc) and very large prostates (VLP: >150 cc). MATERIALS AND METHODS: We retrospectively reviewed 183 patients who underwent STEP using the da Vinci Single-Port system (2019-2024). Patients were stratified into LP and VLP cohorts based on prostate volume (PV). Enucleation efficiency was defined as enucleated tissue weight divided by enucleation time (g/min). Outcomes were compared using descriptive statistics. RESULTS: A total of 179 patients were included (LP: 93; VLP: 86). Median PV was significantly greater in the VLP group (194 vs. 117 cc, p < 0.001). VLP patients had higher PSA (9.7 vs. 6.75 ng/mL, p = 0.002), longer enucleation (84 vs. 69 min, p = 0.002) and console times (115 vs. 98 min, p = 0.010), and improved enucleation efficiency (1.23 vs. 0.97 g/min, p = 0.025). Estimated blood loss was slightly higher in VLP (100 vs. 80 mL, p = 0.026). All procedures were completed without conversion or additional ports. Hospital stay, catheter duration, and same-day discharge rates were comparable. At 3 months, both groups had equivalent improvements in International Prostate Symptom Score (3 vs. 3, p = 0.913), quality-of-life scores (0 vs. 1, p = 0.965), and maximum flow rate (17.5 vs. 16 mL/s, p = 0.594). Complications were rare, with no readmissions and only two major postoperative events. Urinary continence was preserved in all patients, with transient incontinence occurring in 6 patients (LP: 2; VLP: 4), resolving completely by 3 months. CONCLUSIONS: STEP is effective and scalable for prostates ≥ 80 cc, demonstrating improved enucleation efficiency in very large glands without compromising safety, recovery, or continence preservation.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Younis SK, Soputro NA, Pedraza AM, et al. Single-port transvesical enucleation of the prostate (STEP) for benign prostatic hyperplasia: a comparative analysis of patients with large (80-150cc) and very large (>150cc) prostate volumes. Prostate Cancer Prostatic Dis. 2026. PMID: 41723275. doi:10.1038/s41391-026-01074-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。